F8 and hemophilia: The current standard of care for patients with severe hemophilia A and B requires lifelong prophylaxis with an exogenous replacement factor, which is available both as plasma-purified and recombinant protein (FVIII for hemophilia, and FIX for hemophilia B) [152,168].